COVID-19-Related Oral Manifestations: Early Disease Features?
作者信息
Riad Abanoub, Klugar Miloslav, Krsek Martin
机构信息
Faculty of Medicine, Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Center of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
Department of Public Health, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
出版信息
Oral Dis. 2022 Apr;28 Suppl 1(Suppl 1):940-942. doi: 10.1111/odi.13516. Epub 2020 Jul 16.
Abstract
摘要
相似文献
1
COVID-19-Related Oral Manifestations: Early Disease Features?
Oral Dis. 2022 Apr;28 Suppl 1(Suppl 1):940-942. doi: 10.1111/odi.13516. Epub 2020 Jul 16.
2
Oral manifestations in patients with coronavirus disease 2019 (COVID-19) identified using text mining: an observational study.
Sci Rep. 2023 Oct 18;13(1):17770. doi: 10.1038/s41598-023-44784-2.
3
Oral manifestations of COVID-19 in unvaccinated patients: a cross-sectional study.
BMC Oral Health. 2023 Sep 27;23(1):696. doi: 10.1186/s12903-023-03325-z.
4
The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
Med Pr. 2021 Dec 22;72(6):685-692. doi: 10.13075/mp.5893.01135. Epub 2021 Sep 16.
5
Oral manifestations of Covid-19-A literature review.
Rev Med Virol. 2022 Jan;32(1):e2248. doi: 10.1002/rmv.2248. Epub 2021 May 24.
6
Oral manifestations of COVID-2019-related multisystem inflammatory syndrome in children: a review of 47 pediatric patients.
J Am Dent Assoc. 2021 Mar;152(3):202-208. doi: 10.1016/j.adaj.2020.11.014. Epub 2020 Dec 9.
7
Orofacial manifestations of COVID-19: a brief review of the published literature.
Braz Oral Res. 2020 Oct 30;34:e124. doi: 10.1590/1807-3107bor-2020.vol34.0124. eCollection 2020.
8
Oral Manifestations of COVID-19 in Hospitalized Patients: A Systematic Review.
Int J Environ Res Public Health. 2021 Nov 27;18(23):12511. doi: 10.3390/ijerph182312511.
9
Patients with COVID-19 may present some oral manifestations.
Evid Based Dent. 2021 Jan;22(2):80-81. doi: 10.1038/s41432-021-0173-3.
10
COVID-19 and Oral Mucosal Lesions: a Systematic Review.
Clin Ter. 2023 Nov-Dec;174(6):550-563. doi: 10.7417/CT.2023.5024.
引用本文的文献
1
Oral symptoms potentially associated with mild-to-moderate COVID-19 in tobacco users.
Tob Induc Dis. 2024 May 13;22. doi: 10.18332/tid/186531. eCollection 2024.
2
Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases.
Pathogens. 2024 Jan 7;13(1):58. doi: 10.3390/pathogens13010058.
3
Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2.
Int J Environ Res Public Health. 2022 Sep 9;19(18):11383. doi: 10.3390/ijerph191811383.
4
Evaluating Pharmacists' Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia.
Clin Pharmacol. 2022 Apr 5;14:27-35. doi: 10.2147/CPAA.S356413. eCollection 2022.
5
The Oral Complications of COVID-19.
Front Mol Biosci. 2022 Jan 3;8:803785. doi: 10.3389/fmolb.2021.803785. eCollection 2021.
6
Viruses of the oral cavity: Prevalence, pathobiology and association with oral diseases.
Rev Med Virol. 2022 Jul;32(4):e2311. doi: 10.1002/rmv.2311. Epub 2021 Dec 2.
7
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors.
J Fungi (Basel). 2021 Oct 7;7(10):837. doi: 10.3390/jof7100837.
8
Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18-30 Years Old): An Independent Post-Marketing Study.
Pharmaceuticals (Basel). 2021 Oct 15;14(10):1049. doi: 10.3390/ph14101049.
9
Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study.
Vaccines (Basel). 2021 Aug 25;9(9):948. doi: 10.3390/vaccines9090948.
10
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia.
Pharmaceuticals (Basel). 2021 Aug 29;14(9):873. doi: 10.3390/ph14090873.
本文引用的文献
1
Viral enanthema in oral mucosa: A possible diagnostic challenge in the COVID-19 pandemic.
Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):776-778. doi: 10.1111/odi.13473. Epub 2020 Jul 21.
2
Oral cavity lesions as a manifestation of the novel virus (COVID-19).
Oral Dis. 2021 Apr;27 Suppl 3:771-772. doi: 10.1111/odi.13465. Epub 2020 Jul 10.
3
Necrotizing periodontal disease: Oral manifestation of COVID-19.
Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):768-769. doi: 10.1111/odi.13462. Epub 2020 Jun 22.
4
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
J Dermatol Sci. 2020 Jul;99(1):62-64. doi: 10.1016/j.jdermsci.2020.05.002. Epub 2020 May 16.
5
Kawasaki-like disease: emerging complication during the COVID-19 pandemic.
Lancet. 2020 Jun 6;395(10239):1741-1743. doi: 10.1016/S0140-6736(20)31129-6. Epub 2020 May 13.
6
Oral vesiculobullous lesions associated with SARS-CoV-2 infection.
Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):710-712. doi: 10.1111/odi.13382. Epub 2020 May 29.
7
The CARE guidelines: consensus-based clinical case reporting guideline development.
J Med Case Rep. 2013 Sep 10;7:223. doi: 10.1186/1752-1947-7-223.
8
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
BMJ. 2007 Oct 20;335(7624):806-8. doi: 10.1136/bmj.39335.541782.AD.
Zotero 插件